These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

44 related items for PubMed ID: 2521813

  • 1. Presence of a constitutive paracrine beta-interferon in v-mos-bearing nonmalignant reverted cells.
    Gerfaux J, Sergiescu D, Fournier JG, Pochart F, Joret AM, Chany C.
    Cancer Res; 1989 Mar 01; 49(5):1241-6. PubMed ID: 2521813
    [Abstract] [Full Text] [Related]

  • 2. [Mechanism of proliferation of cells transformed by the Moloney mouse sarcoma virus after stable reversion to a non-malignant state].
    Chany C, Kaba A, Jiang PH, Chany-Fournier F.
    C R Acad Sci III; 1993 Nov 01; 316(11):1286-9. PubMed ID: 7522117
    [Abstract] [Full Text] [Related]

  • 3. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.
    Sergiescu D, Gerfaux J, Joret AM, Chany C.
    Proc Natl Acad Sci U S A; 1986 Aug 01; 83(16):5764-8. PubMed ID: 3016718
    [Abstract] [Full Text] [Related]

  • 4. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
    Wietzerbin J, Gaudelet C, Aguet M, Falcoff E.
    J Immunol; 1986 Apr 01; 136(7):2451-5. PubMed ID: 2936825
    [Abstract] [Full Text] [Related]

  • 5. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K, Urawa H, Tamatani T, Iwamura Y, Hashimoto T, Baba T, Suzuki H, Yamada M, Yamamoto S, Oppenheim JJ.
    J Immunol; 1988 Jan 01; 140(1):112-9. PubMed ID: 3275716
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Localization and structure of v-mos in transformed mouse fibroblasts reverted by long-term interferon treatment to nonmalignancy.
    Kaba A, Jiang PH, Chany-Fournier F, Vignal M, Caterina D, Chany C.
    J Interferon Cytokine Res; 1997 Dec 01; 17(12):739-46. PubMed ID: 9452361
    [Abstract] [Full Text] [Related]

  • 9. Novel diversity in Th1, Th2 type differentiation of hemagglutinin-specific T cell clones elicited by natural influenza virus infection in three major haplotypes (H-2b,d,k).
    Graham CM, Smith CA, Thomas DB.
    J Immunol; 1998 Aug 01; 161(3):1094-103. PubMed ID: 9686567
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Down-regulation of Bgp1(a) viral receptor by interferon-gamma is related to the antiviral state and resistance to mouse hepatitis virus 3 infection.
    Vassão RC, de Franco MT, Hartz D, Modolell M, Sippel AE, Pereira CA.
    Virology; 2000 Sep 01; 274(2):278-83. PubMed ID: 10964771
    [Abstract] [Full Text] [Related]

  • 15. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.
    Gerfaux J, Sergiescu D, Hamelin R, Joret AM, Lallemand C.
    Mol Carcinog; 1990 Sep 01; 3(2):103-13. PubMed ID: 2161237
    [Abstract] [Full Text] [Related]

  • 16. Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes.
    Agarwal C, Hembree JR, Rorke EA, Eckert RL.
    Cancer Res; 1994 Apr 15; 54(8):2108-12. PubMed ID: 8174114
    [Abstract] [Full Text] [Related]

  • 17. Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld-restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus.
    Rodewald HR, Koszinowski UH, Eichmann K, Melchers I.
    J Immunol; 1989 Dec 15; 143(12):4238-43. PubMed ID: 2556481
    [Abstract] [Full Text] [Related]

  • 18. Role of interferon-gamma in T-cell responses to Semliki Forest virus-infected murine brain cells.
    Tomkins PT, Ward GA, Morris AG.
    Immunology; 1988 Mar 15; 63(3):355-62. PubMed ID: 2832313
    [Abstract] [Full Text] [Related]

  • 19. Differential regulation of gene expression during macrophage activation with a polyribonucleotide. The role of endogenously derived IFN.
    Riches DW, Henson PM, Remigio LK, Catterall JF, Strunk RC.
    J Immunol; 1988 Jul 01; 141(1):180-8. PubMed ID: 3379303
    [Abstract] [Full Text] [Related]

  • 20. Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages.
    Ling PD, Warren MK, Vogel SN.
    J Immunol; 1985 Sep 01; 135(3):1857-63. PubMed ID: 3926890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.